Enrolling by invitationPhase 3NCT06736691
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
Studying Ankylostomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Swiss Tropical & Public Health Institute
- Principal Investigator
- Jennifer Keiser, ProfessorSwiss Tropical & Public Health Institute
- Intervention
- emodepside (BAY 44-4400)(drug)
- Enrollment
- 315 enrolled
- Eligibility
- 12 years · All sexes
- Timeline
- 2025 – 2026
Study locations (1)
- Public Health Laboratory - Ivo de Carneri (PHL-IdC), Chake Chake, Tanzania
Collaborators
Public Health Laboratory Ivo de Carneri · Bayer · Silicon Valley Community Foundation
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06736691 on ClinicalTrials.govOther trials for Ankylostomiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06282315Real World Evaluation of an Albendazole-Ivermectin Coformulation Safety and EffectivenessInsud Pharma
- RECRUITINGPHASE4NCT07145736Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical DiseasesKirby Institute
- RECRUITINGPHASE3NCT06128447Phase 3, Multi-center, Prospective, Randomized, Double-blind, Placebo- Controlled Study to Evaluate the Effectiveness and Safety of ZP5-9676 for the Treatment of Soil Transmitted Helminthiasis (STH)Zero Point Five Therapeutics
- RECRUITINGPHASE1NCT01940757Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm LarvaeBaylor College of Medicine